Cartesian Therapeutics (RNAC) Insider Trading & Ownership

$21.03
+0.13 (+0.62%)
(As of 04/26/2024 ET)

Cartesian Therapeutics (NASDAQ:RNAC) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
31.20%
Number Of
Insiders Buying
(Last 12 Months)
1
Amount Of
Insider Buying
(Last 12 Months)
$366,519.60
Number Of
Insiders Selling
(Last 12 Months)
0
Get RNAC Insider Trade Alerts

Want to know when executives and insiders are buying or selling Cartesian Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

RNAC Insider Buying and Selling by Quarter

Cartesian Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/18/2024Timothy A SpringerDirectorBuy634$18.00$11,412.00  
3/14/2024Timothy A SpringerDirectorBuy21,612$16.20$350,114.40  
3/11/2024Timothy A SpringerDirectorBuy40$19.50$780.00  
3/8/2024Timothy A SpringerDirectorBuy160$19.80$3,168.00  
2/6/2024Timothy A SpringerDirectorBuy26$19.50$507.00  
1/17/2024Timothy A SpringerDirectorBuy26$20.70$538.20  
(Data available from 1/1/2013 forward)

RNAC Insider Trading Activity - Frequently Asked Questions

Who is on Cartesian Therapeutics's Insider Roster?

The list of insiders at Cartesian Therapeutics includes Timothy A Springer. Learn more on insiders at RNAC.

What percentage of Cartesian Therapeutics stock is owned by insiders?

31.20% of Cartesian Therapeutics stock is owned by insiders. Learn more on RNAC's insider holdings.

Which Cartesian Therapeutics insiders have been buying company stock?

The following insider purchased RNAC shares in the last 24 months: Timothy A Springer ($366,519.60).

How much insider buying is happening at Cartesian Therapeutics?

Insiders have purchased a total of 22,498 RNAC shares in the last 24 months for a total of $366,519.60 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:RNAC) was last updated on 4/27/2024 by MarketBeat.com Staff

From Our Partners